<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Microtubule integrity is important in cardio-protection, and microtubule disruption has been implicated in the response to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in cardiac myocytes </plain></SENT>
<SENT sid="1" pm="."><plain>However, the effects of <z:chebi fb="6" ids="45863">Taxol</z:chebi>, a common microtubule stabilizer, are still unknown in ischemic <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> model was established in isolated rat hearts by regional <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> model by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Microtubule structure was immunohistochemically measured </plain></SENT>
<SENT sid="4" pm="."><plain>The potential mechanisms were studied by measuring reactive oxygen species (ROS), activities of oxidative enzymes, intracellular calcium concentration ([Ca(2+) ](i) ) and Ca(2+) transients by using fluorometric determination, spectrophotometric assays and Fura-2-AM and <z:chebi fb="0" ids="5107">Fluo-3</z:chebi>-AM, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The expression and activity of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a) was also examined using real-time polymerase chain reaction, Western blot and <z:chebi fb="1" ids="15361">pyruvate</z:chebi>/<z:chebi fb="0" ids="13389">Nicotinamide adenine dinucleotide</z:chebi>-coupled reaction </plain></SENT>
<SENT sid="6" pm="."><plain>Our data showed that <z:chebi fb="6" ids="45863">Taxol</z:chebi> (0.1, 0.3 and 1 μM) effectively reduced the number of <z:mp ids='MP_0009732'>ventricular premature beats</z:mp> and the incidence and duration of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> size was also significantly reduced by <z:chebi fb="6" ids="45863">Taxol</z:chebi> (1 μM) </plain></SENT>
<SENT sid="8" pm="."><plain>At the same time, <z:chebi fb="6" ids="45863">Taxol</z:chebi> preserved the microtubule structure, increased the activity of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> electron transport chain complexes I and III, reduced ROS levels, decreased the rise in [Ca(2+)](i) and preserved the amplitude and decay times of Ca(2+) transients during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, SERCA2a activity was preserved by <z:chebi fb="6" ids="45863">Taxol</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In summary, <z:chebi fb="6" ids="45863">Taxol</z:chebi> prevents ischemic <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> likely through ameliorating abnormal calcium homeostasis and decreasing the level of ROS </plain></SENT>
<SENT sid="11" pm="."><plain>This study presents evidence that <z:chebi fb="6" ids="45863">Taxol</z:chebi> may be a potential novel therapy for ischemic <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
</text></document>